← Back
Data updated: Mar 10, 2026
SENTYNL THERAPS INC
Pharmaceuticals
SENTYNL THERAPS INC is a pharmaceutical company with 4 FDA-approved products.
2011
Since
4
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
Recent Activity
ZYCUBO 2026-01-12
Type 1 - New Molecular Entity
ZOKINVY 2024-03-21
Labeling
ZOKINVY 2024-03-21
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...